MedKoo Cat#: 596993 | Name: Cysteine hydrazide

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Cysteine hydrazide is an enrichment tool for the mass spectrometric characterization of bacterial free oligosaccharides.

Chemical Structure

Cysteine hydrazide
Cysteine hydrazide
CAS#58100-26-8

Theoretical Analysis

MedKoo Cat#: 596993

Name: Cysteine hydrazide

CAS#: 58100-26-8

Chemical Formula: C3H9N3OS

Exact Mass: 135.0466

Molecular Weight: 135.18

Elemental Analysis: C, 26.65; H, 6.71; N, 31.08; O, 11.83; S, 23.72

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Cysteine hydrazide; Cysteine, hydrazide, L-; L-Cysteine, hydrazide;
IUPAC/Chemical Name
(R)-2-amino-3-mercaptopropanehydrazide
InChi Key
IQIYDJRAZKPGKO-REOHCLBHSA-N
InChi Code
InChI=1S/C3H9N3OS/c4-2(1-8)3(7)6-5/h2,8H,1,4-5H2,(H,6,7)/t2-/m0/s1
SMILES Code
N[C@@H](CS)C(NN)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 135.18 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Jang KS, Nani RR, Kalli A, Levin S, Müller A, Hess S, Reisman SE, Clemons WM Jr. A cationic cysteine-hydrazide as an enrichment tool for the mass spectrometric characterization of bacterial free oligosaccharides. Anal Bioanal Chem. 2015 Aug;407(20):6181-90. doi: 10.1007/s00216-015-8798-8. Epub 2015 Jun 23. PubMed PMID: 26100547; PubMed Central PMCID: PMC4539134. 2: Vogel CW. Preparation of immunoconjugates using antibody oligosaccharide moieties. Methods Mol Biol. 2004;283:87-108. PubMed PMID: 15197304. 3: Zara J, Pomato N, McCabe RP, Bredehorst R, Vogel CW. Cobra venom factor immunoconjugates: effects of carbohydrate-directed versus amino group-directed conjugation. Bioconjug Chem. 1995 Jul-Aug;6(4):367-72. PubMed PMID: 7578355. 4: Zara JJ, Wood RD, Boon P, Kim CH, Pomato N, Bredehorst R, Vogel CW. A carbohydrate-directed heterobifunctional cross-linking reagent for the synthesis of immunoconjugates. Anal Biochem. 1991 Apr;194(1):156-62. PubMed PMID: 1867379. 5: Błaszczyk B, Giełdanowski J, Woźniak M, Dobryszycka W, Lemmel EM, Katkiewicz M, Viljanen M. Azimexone and cysteine hydrazide in the treatment of allergic encephalomyelitis. Arch Immunol Ther Exp (Warsz). 1988;36(3):217-27. PubMed PMID: 3266915. 6: Wieczorek Z, Spiegel K, Ryzewski J, Zimecki M. Effect of hydrazide cysteine on the humoral immune response of mice to sheep erythrocytes. Arch Immunol Ther Exp (Warsz). 1987;35(2):193-200. PubMed PMID: 3447534. 7: Zimecki M, Zwoliński J, Ryzewski J, Wieczorek Z. Effect of hydrazide cysteine on T cells. II. Human autologous rosette forming cells belong to two subpopulations differing with respect to the sensitivity to hydrocortisone and hydrazide cysteine. Arch Immunol Ther Exp (Warsz). 1984;32(3):281-5. PubMed PMID: 6335390. 8: Zimecki M, Ryzewski J, Wieczorek Z. Effect of hydrazide cysteine on T cells. I. Hydrazide cysteine changes the sensitivity of murine T lymphocytes to hydrocortisone and their ability to form autologous rosettes. Arch Immunol Ther Exp (Warsz). 1984;32(3):269-79. PubMed PMID: 6335389. 9: Ryzewski J, Giełdanowski J, Raberger G, Kossakowska M. L-cysteine hydrazide--its pharmacological and immunosuppressive activity. Arch Immunol Ther Exp (Warsz). 1979;27(6):733-47. PubMed PMID: 317699. 10: Kwapiszewski W, Iliaszenko J, Sokołowska-Muszyńska M. Synthesis of L-cysteine derivatives of immunotropic activity. Arch Immunol Ther Exp (Warsz). 1978;26(1-6):917-9. PubMed PMID: 749840. 11: Ryzewski J, Kossakowska M, Krzystyniak K. Influence of the cysteine derivatives on the cell-mediated immunity. Arch Immunol Ther Exp (Warsz). 1978;26(1-6):913-6. PubMed PMID: 749839. 12: Krzystyniak K, Ryzewski J, Chwaliński S. Studies on the influence of thiols on lymphocytes (T-type lymphocytes) functions. Arch Immunol Ther Exp (Warsz). 1978;26(1-6):367-70. PubMed PMID: 312073. 13: Ryzewski J, Krzystyniak K. Studies on the influence of thiols on lymphocytes (T-type lymphocytes) function. Arch Immunol Ther Exp (Warsz). 1978;26(1-6):361-5. PubMed PMID: 312072.